Eriodictyol Attenuates Cholangiocarcinoma Malignancy by Regulating HMOX1 Expression: An Study.

Background/aim: Cholangiocarcinoma remains one of the most dangerous types of cancer. Eriodictyol is a well-known flavonoid having effective bioactivity against various malignant tumor types. However, the anticancer effect of eriodictyol against cholangiocarcinoma remains ambiguous.